Brief: CSPC Pharmaceutical Group Posts Q1 Net Income Attributable RMB859.8 Million
27/05/2026 05:11
BRIEF-CSPC Pharmaceutical Group Posts Q1 Net Income Attributable RMB859.8 Million May 27 (Reuters) - CSPC Pharmaceutical Group:
- Q1 net income attributable RMB 859.8 million
- Q1 revenue RMB6,465.3 million
Recent news on CSPC PHARMACEUTICAL
See all newsBrief: CSPC Pharmaceutical Posts CSPC Innovation Pharmaceutical 9M Net Profit Attributable RMB 1.21 Billion
Brief: CSPC Pharmaceutical Publishes Updated Phase III OS Results For Anbenitamab In Her2-Positive Advanced Gastric Cancer
Brief: CSPC Pharmaceutical Says Batoclimab Injection (Enlida) Obtains Drug Registration Certificate From NMPA
Brief: CSPC Pharmaceutical Initiates Phase III Trial Of SYS6043 For Triple-Negative Breast Cancer In China
Factbox: Pharma sector doubles down on AI to slash costs, timelines